Your session is about to expire
← Back to Search
Dietary Supplement
Trulacta breastmilk supplement for Aging
Phase 2
Recruiting
Research Sponsored by TruDiagnostic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up testing will compare results from baseline to completion of 3 months of the supplement
Awards & highlights
Study Summary
This trial will test if the Trulacta supplement has any effect on biological age, sleep quality, immune system, and wellness markers.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ testing will compare results from baseline to completion of 3 months of the supplement
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~testing will compare results from baseline to completion of 3 months of the supplement
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Epigenetic Age
Secondary outcome measures
Sleep Quality
Trial Design
1Treatment groups
Experimental Treatment
Group I: Trulacta breastmilk supplementExperimental Treatment1 Intervention
Once daily Trulacta supplement
Find a Location
Who is running the clinical trial?
Adventa BiosciencesUNKNOWN
TruDiagnosticLead Sponsor
11 Previous Clinical Trials
456 Total Patients Enrolled
8 Trials studying Aging
346 Patients Enrolled for Aging
Share this study with friends
Copy Link
Messenger